全球透明質酸注射劑市場規模、佔有率、趨勢和成長分析報告（膝關節注射，2026-2034年）

預計膝關節透明質酸注射劑的市場規模將從 2025 年的 19.6 億美元成長到 2034 年的 33.5 億美元，2026 年至 2034 年的複合年成長率為 6.12%。

由於骨關節炎和關節相關疾病的盛行率不斷上升，全球膝關節透明質酸注射劑市場正經歷強勁成長。這些注射劑透過潤滑膝關節來緩解疼痛並改善關節活動度。人口老化和對非手術治療方法需求的成長是推動市場擴張的主要因素。此外，人們對早期療育和關節護理意識的提高也促進了市場需求。

成長要素包括注射配方技術的進步以及人們對微創治療日益成長的偏好。玻尿酸注射因其能暫時緩解疼痛並延緩手術需求而廣受患者歡迎。醫療基礎設施的擴張和整形外科治療服務的改善也促進了市場成長。此外，持續的研究正在不斷提高產品的療效和延長止痛持續時間。

未來，隨著治療技術的不斷進步，膝關節透明化酸注射市場預計將穩定成長。更持久、更有效的配方研發將進一步促進其普及。在新興市場，健康意識的提高可能帶來巨大的成長機會。此外，人們對預防醫學和早期診斷的日益關注也將推動市場擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球膝關節透明酸注射市場：依產品分類

• 市場分析、洞察與預測
• 膝關節單劑量透明酸注射
• 膝關節三次注射透明酸
• 膝蓋注射5劑玻尿酸
• 下一代（含類固醇）

第5章：全球膝關節透明酸注射市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 門診手術中心
• 整形外科診所
• 零售藥房
• 線上銷售

第6章：全球膝關節透明酸注射市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Sanofi SA
  • Bioventus LLC
  • Ferring BV
  • Zimmer Biomet
  • Seikagaku Corporation
  • Fidia Farmaceutici Spa
  • Anika Therapeutics Inc
  • LG Chem
  • OrthogenRx
  • Hanmi Pharm. Co. Ltd
  • Chugai Pharmaceutical Co. Ltd
  • Haohai Biological Technology

The Knee Hyaluronic Acid Injections Market size is expected to reach USD 3.35 Billion in 2034 from USD 1.96 Billion (2025) growing at a CAGR of 6.12% during 2026-2034.

The global knee hyaluronic acid injections market is experiencing strong growth due to the increasing prevalence of osteoarthritis and joint-related disorders. These injections are used to relieve pain and improve joint mobility by lubricating the knee joint. The growing aging population and rising demand for non-surgical treatment options are key factors driving market expansion. Additionally, increasing awareness about early intervention and joint care is supporting demand.

Key growth drivers include advancements in injectable formulations and the increasing preference for minimally invasive treatments. Hyaluronic acid injections provide temporary relief and delay the need for surgical procedures, making them widely accepted among patients. The expansion of healthcare infrastructure and increasing access to orthopedic treatments are also contributing to market growth. Furthermore, ongoing research is improving product efficacy and duration of relief.

Looking ahead, the knee hyaluronic acid injections market is expected to grow steadily with continuous advancements in treatment technologies. The development of longer-lasting and more effective formulations will further drive adoption. Emerging markets are likely to provide significant growth opportunities due to rising healthcare awareness. Additionally, increasing focus on preventive care and early diagnosis will support market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Single Injection Knee Hyaluronic Acid Injections
• Three Injection Knee Hyaluronic Acid Injections
• Five Injection Knee Hyaluronic Acid Injections
• Next Generation (Steroid Combination)

By End User

• Hospitals
• Ambulatory Surgical Centers
• Orthopedic Clinics
• Retail Pharmacies
• Online Sales

COMPANIES PROFILED

• Sanofi SA, Bioventus LLC, Ferring BV, Zimmer Biomet, Seikagaku Corporation, Fidia Farmaceutici spa, Anika Therapeutics Inc, LG Chem, OrthogenRx, Hanmi Pharm Co Ltd, Chugai Pharmaceutical Co Ltd, Haohai Biological Technology
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL KNEE HYALURONIC ACID INJECTIONS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Single Injection Knee Hyaluronic Acid Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Three Injection Knee Hyaluronic Acid Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Five Injection Knee Hyaluronic Acid Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Next Generation (Steroid Combination) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL KNEE HYALURONIC ACID INJECTIONS MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Orthopedic Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Online Sales Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL KNEE HYALURONIC ACID INJECTIONS MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By End User
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By End User
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By End User
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By End User
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By End User
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL KNEE HYALURONIC ACID INJECTIONS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Sanofi S.A
  • 8.2.2 Bioventus LLC
  • 8.2.3 Ferring B.V
  • 8.2.4 Zimmer Biomet
  • 8.2.5 Seikagaku Corporation
  • 8.2.6 Fidia Farmaceutici S.p.a
  • 8.2.7 Anika Therapeutics Inc
  • 8.2.8 LG Chem
  • 8.2.9 OrthogenRx
  • 8.2.10 Hanmi Pharm. Co. Ltd
  • 8.2.11 Chugai Pharmaceutical Co. Ltd
  • 8.2.12 Haohai Biological Technology